CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
Over the last 12 months, insiders at CervoMed Inc. have bought $18,160 and sold $0 worth of CervoMed Inc. stock.
On average, over the past 5 years, insiders at CervoMed Inc. have bought $18,160 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: ELDER WILLIAM ROBERT (CFO & GC) — $18,160.
The last purchase of 1,000 shares for transaction amount of $18,160 was made by ELDER WILLIAM ROBERT (CFO & GC) on 2024‑08‑27.
2024-08-27 | CFO & GC | 1,000 0.0132% | $18.16 | $18,160 | -20.94% |